Moreover, wild-type GCase activity is decreased in both idiopathic and multiple types of familial PD patient neurons9,16–20, highlighting targeting of GBA1 as a potential therapeutic approach for PD14,16,21 and a key role for GCase activity in PD pathogenesis. The gene discussed is GBA1; the disease is Parkinson disease.